Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Abdullah H. Alshurafa
Observed names:
Abdullah Alshurafa,
Abdullah H Alshurafa
Observed institution:
University of Jordan
ORCID:
0000-0001-7002-5631
Observed ORCID:
0000-0001-7002-5631
OpenAlex ID:
A5073754366
Mortality, Intensive Care Unit Admission, and Intubation among Hospitalized Patients with COVID-19: A One-Year Retrospective Study in Jordan
2023
·
Khaled Al Oweidat
, Rasmieh Al-Amer
, et al.
·
Journal of Clinical Medicine
·
9
PDF
New symptoms and prevalence of postacute COVID-19 syndrome among nonhospitalized COVID-19 survivors
2022
·
Asma S. Albtoosh
, Ahmad A. Toubasi
, et al.
·
Scientific Reports
·
9
PDF
Prevalence and impact of pulmonary hypertension on acute decompensated heart failure with preserved ejection fraction hospitalizations: A five-year retrospective analysis
2024
·
Omar Al Wahadneh
, Qusai Alitter
, et al.
·
Current Problems in Cardiology
·
3
POSTER: ALL-1212: Post-Induction Consolidation With Blinatumomab vs Chemotherapy in First-Relapse B-Cell Acute Lymphoblastic Leukemia: Evidence From Randomized Controlled Trials
2026
·
Bashar M Al Zoubi
, Abdullah H Alshurafa
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
ALL-1212: Post-Induction Consolidation With Blinatumomab vs Chemotherapy in First-Relapse B-Cell Acute Lymphoblastic Leukemia: Evidence From Randomized Controlled Trials
2026
·
Bashar M Al Zoubi
, Abdullah H Alshurafa
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: ABCL-1318: Efficacy and Safety of Programmed Cell Death-1 Inhibitors in Relapsed Immune-Privileged Site Lymphomas: A Systematic Review and Meta-Analysis
2026
·
Bashar M Al Zoubi
, Ahmad Anshasi
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
ABCL-1318: Efficacy and Safety of Programmed Cell Death-1 Inhibitors in Relapsed Immune-Privileged Site Lymphomas: A Systematic Review and Meta-Analysis
2026
·
Bashar M Al Zoubi
, Ahmad Anshasi
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Environmental Risk Factors for Inflammatory Bowel Diseases in Jordan: A Matched Case–control Study
2025
·
Assem Al Refaei
, Nour Shewaikani
, et al.
·
JAP Academy Journal
IBD Diagnosis Delay and Its Predictors in Jordan: A Retrospective Study
2024
·
Assem Al Refaei
, Nour Shewaikani
, et al.
·
JAP Academy Journal
Show more works
View as search
Works count:
9
Citation count:
21
H-index:
3
I10-index:
Year
Topic
Type
